In The $850m Cannabis Testing Market, Signal Bay Makes Strategic Acquisition

Washington Through its CANNAiQ(TM) B2B information portal, the company provides an enterprise version of MassRoots Inc.’s (OTCQB:MSRT) consumer platform.

Signal Bay is investigating the proposed “research” license mentioned in Oregon’s HB3400, for example, which could lead to a move into the pharmaceutical side of the space alongside companies like GW Pharmaceuticals plc (NASDAQ:GWPH) or Insys Therapeutics Inc. (NASDAQ:INSY).

To read more, visit http://finance.yahoo.com/news/signal-bay-makes-strategic-acquisition-132000592.html

Posted in: Investing

Comments are closed.